B·R·A·H·M·S Innovative Biomarkers

Improve early diagnosis and treatment of life-threatening diseases with B·R·A·H·M·S biomarkers

Discover the benefits of B·R·A·H·M·S

Assays that support clinical diagnostics

Rapid diagnosis is the first step towards a cure. Thermo Scientific™ B·R·A·H·M·S™ Biomarkers play a vital role in prenatal screening, identifying sepsis and infection, and detecting cardiovascular disorders, tumours, cancer disorders and thyroid diseases. 

  Informational: This product is not available for purchase by the general public

Why Thermo Fisher Scientific?

The Thermo Scientific B·R·A·H·M·S patented biomarkers are innovative assays trusted by medical professionals to deliver superior diagnostic insights and improve patient outcomes.

 

We offer:

  • Comprehensive, reliable immunodiagnostic testing products that include the B·R·A·H·M·S biomarkers PCT, MR-proADM, Copeptin proAVP and CgA II KRYPTOR for early detection of clinical disorders
  • Trusted preeclampsia risk and trisomy screening in pregnant patients
  • Instrumentation, including KRYPTOR analysers
  • Assays are available in different formats, including the fully-automated KRYPTOR version with TRACE technology and conventional technologies such as radioimmunoassay
  • Global expertise with localised support – we have an extensive worldwide network and knowledge base to complement our biomarkers product range

Clinical fields of indication for B·R·A·H·M·S biomarkers

The Thermo Scientific B·R·A·H·M·S patented biomarkers focus on the following fields of clinical diagnosis: infectious disease, prenatal screening, cardiovascular disease, endocrinology and metabolic disorders and oncology. We also support analysis through the measurement of biomarkers with Thermo Scientific™ KRYPTOR™ analysers.

Prenatal screening

B·R·A·H·M·S provides a complete prenatal screening biomarker portfolio that can screen for preeclampsia and chromosomal abnormalities. Prenatal screening can save lives and improve livelihoods through early risk assessment for diseases and other medical conditions. 

Cardiovascular disease

The biomarker B·R·A·H·M·S Copeptin proAVP is a reliable surrogate marker of vasopressin and can be used to rule out acute myocardial infarction (AMI) with Troponin and diagnose water balance disorders. Watch the webinar "Understanding the Copeptin Biomarker" to learn more about the intricacies of copeptin.

Oncology

Tumour markers help follow up and manage patients with cancer, and Thermo Scientific offers a broad range, including the B·R·A·H·M·S CgA II KRYPTOR (Chromogranin A) for therapy monitoring of neuroendocrine tumours and prostate cancer. 

Endocrinology and metabolic disorders

Thyroid diseases rank among the most frequent medical conditions. As a result, they do not only affect the quality of life of the individual patient but also impose considerable costs on society as a whole. For thyroid diseases, measurement of in vitro parameters is critical to diagnosis, differential diagnosis, and clinical decisions to be made in the course of the condition. Thermo Scientific B·R·A·H·M·S Biomarkers is a market leader for a variety of tests, such as the TSH receptor antibody test (TRAK).

Infectious disease

Early detection of infection improves patient outcomes and reduces costs associated with unnecessary treatments at medical facilities. The B·R·A·H·M·S PCT (Procalcitonin) aids in the early detection of sepsis whilst the B·R·A·H·M·S MR-proADM (Mid-regional proADrenoMedullin) can identify microcirculatory and endothelial damage. 

Learn more about reducing antibiotic exposure with B·R·A·H·M·S PCT (Procalcitonin) sensitive KRYPTOR. An effective tool to aid in antibiotic stewardship and assessing the risk of bacterial infection.

See how PCT monitoring can offer insights for patient assessment and therapeutic decision making.

B·R·A·H·M·S KRYPTOR analysers

The clinical decision-making process relies on the reliable measuring of biomarker results. B·R·A·H·M·S KRYPTOR Analysers are fully automatic, closed laboratory systems that can perform various analyses in random-access operations using a unique measuring principle called TRACE (Time Resolved Amplified Cryptate Emission), designed by Nobel-prize winning chemist Jean-Marie Lehn. 

The availability of products may vary in each country depending on local regulatory requirements.

Contact your local specialist for more details